These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 9184201)
1. Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a four-week study in cynomolgus monkeys. Henry SP; Bolte H; Auletta C; Kornbrust DJ Toxicology; 1997 Jun; 120(2):145-55. PubMed ID: 9184201 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a 4-week study in CD-1 mice. Henry SP; Taylor J; Midgley L; Levin AA; Kornbrust DJ Antisense Nucleic Acid Drug Dev; 1997 Oct; 7(5):473-81. PubMed ID: 9361906 [TBL] [Abstract][Full Text] [Related]
3. Correlation of toxicity and pharmacokinetic properties of a phosphorothioate oligonucleotide designed to inhibit ICAM-1. Henry SP; Templin MV; Gillett N; Rojko J; Levin AA Toxicol Pathol; 1999; 27(1):95-100. PubMed ID: 10367680 [TBL] [Abstract][Full Text] [Related]
4. Toxicity and toxicokinetics of a phosphorothioate oligonucleotide against the c-myc oncogene in cynomolgus monkeys. Webb MS; Tortora N; Cremese M; Kozlowska H; Blaquiere M; Devine DV; Kornbrust DJ Antisense Nucleic Acid Drug Dev; 2001 Jun; 11(3):155-63. PubMed ID: 11446591 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of coagulation by a phosphorothioate oligonucleotide. Henry SP; Novotny W; Leeds J; Auletta C; Kornbrust DJ Antisense Nucleic Acid Drug Dev; 1997 Oct; 7(5):503-10. PubMed ID: 9361909 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the renal effects of an antisense phosphorothioate oligodeoxynucleotide in monkeys. Monteith DK; Horner MJ; Gillett NA; Butler M; Geary R; Burckin T; Ushiro-Watanabe T; Levin AA Toxicol Pathol; 1999; 27(3):307-17. PubMed ID: 10356707 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the toxicity profiles of ISIS 1082 and ISIS 2105, phosphorothioate oligonucleotides, following subacute intradermal administration in Sprague-Dawley rats. Henry SP; Grillone LR; Orr JL; Bruner RH; Kornbrust DJ Toxicology; 1997 Jan; 116(1-3):77-88. PubMed ID: 9020509 [TBL] [Abstract][Full Text] [Related]
8. Toxicological properties of several novel oligonucleotide analogs in mice. Henry SP; Zuckerman JE; Rojko J; Hall WC; Harman RJ; Kitchen D; Crooke ST Anticancer Drug Des; 1997 Jan; 12(1):1-14. PubMed ID: 9051110 [TBL] [Abstract][Full Text] [Related]
9. A randomized, placebo controlled trial of an antisense oligodeoxynucleotide to intercellular adhesion molecule-1 in the treatment of severe rheumatoid arthritis. Maksymowych WP; Blackburn WD; Tami JA; Shanahan WR J Rheumatol; 2002 Mar; 29(3):447-53. PubMed ID: 11908555 [TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of the effects of a novel antisense compound targeting C-raf kinase in mice and monkeys. Monteith DK; Geary RS; Leeds JM; Johnston J; Monia BP; Levin AA Toxicol Sci; 1998 Dec; 46(2):365-75. PubMed ID: 10048140 [TBL] [Abstract][Full Text] [Related]
11. Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex. Sheehan JP; Lan HC Blood; 1998 Sep; 92(5):1617-25. PubMed ID: 9716589 [TBL] [Abstract][Full Text] [Related]
12. Renal uptake and tolerability of a 2'-O-methoxyethyl modified antisense oligonucleotide (ISIS 113715) in monkey. Henry SP; Johnson M; Zanardi TA; Fey R; Auyeung D; Lappin PB; Levin AA Toxicology; 2012 Nov; 301(1-3):13-20. PubMed ID: 22709826 [TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of the toxicological effects of a novel constrained ethyl modified antisense compound targeting signal transducer and activator of transcription 3 in mice and cynomolgus monkeys. Burel SA; Han SR; Lee HS; Norris DA; Lee BS; Machemer T; Park SY; Zhou T; He G; Kim Y; MacLeod AR; Monia BP; Lio S; Kim TW; Henry SP Nucleic Acid Ther; 2013 Jun; 23(3):213-27. PubMed ID: 23692080 [TBL] [Abstract][Full Text] [Related]
14. Effects of human and murine antisense oligonucleotide inhibitors of ICAM-1 on reproductive performance, fetal development, and post-natal development in mice. Henry SP; Denny KH; Templin MV; Yu RZ; Levin AA Birth Defects Res B Dev Reprod Toxicol; 2004 Dec; 71(6):359-67. PubMed ID: 15617021 [TBL] [Abstract][Full Text] [Related]
15. Phase I and phase II safety and efficacy trial of intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302) for the prevention of acute allograft rejection. Kahan BD; Stepkowski S; Kilic M; Katz SM; Van Buren CT; Welsh MS; Tami JA; Shanahan WR Transplantation; 2004 Sep; 78(6):858-63. PubMed ID: 15385805 [TBL] [Abstract][Full Text] [Related]
16. Effects of an antisense oligonucleotide inhibitor of human ICAM-1 on fetal development in rabbits. Henry SP; Denny KH; Templin MV; Yu RZ; Levin AA Birth Defects Res B Dev Reprod Toxicol; 2004 Dec; 71(6):368-73. PubMed ID: 15617022 [TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamics and subchronic toxicity in mice and monkeys of ISIS 388626, a second-generation antisense oligonucleotide that targets human sodium glucose cotransporter 2. Zanardi TA; Han SC; Jeong EJ; Rime S; Yu RZ; Chakravarty K; Henry SP J Pharmacol Exp Ther; 2012 Nov; 343(2):489-96. PubMed ID: 22915769 [TBL] [Abstract][Full Text] [Related]
19. Activation of the alternative pathway of complement by a phosphorothioate oligonucleotide: potential mechanism of action. Henry SP; Giclas PC; Leeds J; Pangburn M; Auletta C; Levin AA; Kornbrust DJ J Pharmacol Exp Ther; 1997 May; 281(2):810-6. PubMed ID: 9152389 [TBL] [Abstract][Full Text] [Related]